Axinesis
Founded 2015 · 7 employees on LinkedIn · 2 known investors
Find your way into Axinesis
568 people in our graph share verified history with the Axinesis team — schools, employers, funds. One of them is your warm intro.
Pierre de Wahaunlockedknows Pieter Van den Steen · together at Axinesis (overlapped)
×4knows the team · via JenaValve Technology, Inc.
knows the team · via Schering-Plough Germany (Essex Pharma)
×4knows the team · via Johnson & Johnson
×2knows the team · via Unilabs
Axinesis develops CE-marked robotic rehabilitation devices for patients with motor and cognitive disorders across acute and home-care settings. The company offers innovative neurorehabilitation technologies to optimize functional recovery throughout the patient care pathway.
Founders & leadership
Axinesis was founded in 2015 by Julien Sapin.
JS

Julien SapinFounder & CTOJulien Sapin holds a PhD in mechatronics engineering from Université catholique de Louvain and previously developed robotic neurorehabilitation devices before founding Axinesis, a medtech company that initially commercialized rehabilitation systems and currently operates as a contract development and manufacturing organization for medical devices.
PV

Pieter Van den SteenCEOPieter Van den Steen is a healthcare executive with over 25 years of experience in medical devices, diagnostics, and digital therapeutics across start-ups and multinational organizations. He has held CEO and commercial leadership roles managing businesses with significant revenues and multidisciplinary teams across Europe and global markets.
Investors · 2
Frequently asked questions
- What does Axinesis do?
- Axinesis develops CE-marked robotic rehabilitation devices for patients with motor and cognitive disorders across acute and home-care settings. The company offers innovative neurorehabilitation technologies to optimize functional recovery throughout the patient care pathway.
- Who founded Axinesis?
- Axinesis was founded by Julien Sapin in 2015.
- Who are Axinesis's investors?
- Axinesis's investors include Nivelinvest, VIVES Partners.


